Prognostic value of the neutrophil-lymphocyte ratio and CA 19-9 in predicting survival inpatients with metastatic pancreatic cancer

Basit Öğe Kaydı
dc.contributor.authorDede, I.
dc.contributor.authorCetin, M.
dc.contributor.authorCetin, S.
dc.date.accessioned2024-09-18T21:01:42Z
dc.date.available2024-09-18T21:01:42Z
dc.date.issued2018
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description43rd ESMO Congress (ESMO) -- OCT 19-23, 2018 -- Munich, GERMANYen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipEuropean Soc Med Oncol,Japanese Soc Med Oncolen_US
dc.identifier.endpage256en_US
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.startpage256en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12483/12957
dc.identifier.volume29en_US
dc.identifier.wosWOS:000459277301329en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherOxford Univ Pressen_US
dc.relation.ispartofAnnals of Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titlePrognostic value of the neutrophil-lymphocyte ratio and CA 19-9 in predicting survival inpatients with metastatic pancreatic canceren_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu